Our study highlights the critical role of NOTCH3-SPP1-PI3K/AKT axis in the malignant progression of BLCA, suggesting that NOTCH3 may be a potential therapeutic target for BLCA. The gene discussed is AKT1; the disease is bladder transitional cell carcinoma.